Founded at the Abramson Cancer Center at the University of Pennsylvania

Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy

Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy

JCO Precision Oncology | 2021

Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, Jamie Rosenstein, Austin L Chien, Katie Quinn, Carin R Espenschied, Allysia Mak, Lesli A Kiedrowski, Martina Lefterova, Rebecca J Nagy, Sharyn I Katz, Stephanie S Yee, Taylor A Black, Aditi P Singh, Christine A Ciunci, Joshua M Bauml, Roger B Cohen, Corey J Langer, Charu Aggarwal